Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thromboembolic Risk”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableActive Not RecruitingNCT05548062
What this trial is testing

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 242
Not applicableStudy completedNCT02987946
What this trial is testing

Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events

Who this might be right for
Deep-Venous Thrombosis
Leiden University Medical Center 280
Large-scale testing (Phase 3)Study completedNCT01675076
What this trial is testing

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

Who this might be right for
Hematoma
Ottawa Heart Institute Research Corporation 663
Not applicableLooking for participantsNCT03206372
What this trial is testing

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Brest 2,640
Not applicableStudy completedNCT01277536
What this trial is testing

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

Who this might be right for
Venous Thromboembolism
University Hospital, Geneva 1,478
Not applicableNot Yet RecruitingNCT07278648
What this trial is testing

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

Who this might be right for
Acute Disease
Consorci Sanitari de l'Alt Penedès i Garraf 150
Not applicableLooking for participantsNCT07288632
What this trial is testing

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Who this might be right for
Venous Thromboembolism (VTE)NSCLC (Advanced Non-small Cell Lung Cancer)
University Of Perugia 500
Not applicableUnknownNCT04001205
What this trial is testing

Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

Who this might be right for
Atrial FibrillationStroke, Ischemic
University of Turku 1,300
Not applicableUnknownNCT04681014
What this trial is testing

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionPulmonary Embolism
iPHNET (italian Pulmonary Hypertension NETwork) 1,218
Not applicableStudy completedNCT03894878
What this trial is testing

Association Between Genetic Variant Scores and Warfarin Effect

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisIntracardiac Thrombus+2 more
Cipherome, Inc. 200
Not applicableStudy completedNCT02025894
What this trial is testing

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

Who this might be right for
Cancer
Institut de Cancérologie de la Loire 3,032
Large-scale testing (Phase 3)Study completedNCT00038961
What this trial is testing

Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

Who this might be right for
Thromboembolism
GlaxoSmithKline 1,309
Not applicableWithdrawnNCT01710150
What this trial is testing

Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter

Who this might be right for
Typical Atrial FlutterRisk Factors With Future Development of Atrial Flutter
University of Pennsylvania
Not applicableLooking for participantsNCT07016542
What this trial is testing

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Rouen 2,000
Not applicableStudy completedNCT04064489
What this trial is testing

Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.

Who this might be right for
Lower Limb TraumaVenous ThromboembolismStratification
University Hospital, Angers 2,123
Not applicableLooking for participantsNCT05684770
What this trial is testing

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk

Who this might be right for
Thromboembolic Disease
Centre Hospitalier Eure-Seine 50
Not applicableStudy completedNCT04616846
What this trial is testing

Thromboembolic Risk Screening in Patients With Cancer and COVID-19

Who this might be right for
Neoplasms MalignantCovid19Thromboembolism
Centre Antoine Lacassagne 88
Not applicableWithdrawnNCT05618093
What this trial is testing

Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH

Who this might be right for
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
University of California, Los Angeles
Not applicableUnknownNCT03470207
What this trial is testing

The Prospective Risk Factor Evaluation & Discovery In CTEPH Study

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Mark W. Dodson 130
Large-scale testing (Phase 3)UnknownNCT02313584
What this trial is testing

Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk

Who this might be right for
Atrial FibrillationThromboembolism
Korea University 464
Load More Results